Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for preventing and treating colon cancer

A composition and technology for colon cancer, applied in the field of medicine, can solve the problems of slow effect, insufficient therapeutic effect, and inability to inhibit tumor growth, etc., and achieve rapid and remarkable curative effect

Inactive Publication Date: 2015-07-01
吴旭
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the existing traditional Chinese medicines for the treatment of colon cancer are not effective enough, and the effect is relatively slow, so that patients with colon cancer cannot inhibit tumor growth, or the tumor recurs, metastasizes, and spreads after surgery.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0008] Example 1, a pharmaceutical composition for preventing and treating colon cancer, the materials are composed by weight: 20 parts of angelica, 14 parts of Sanqi, 12 parts of rhubarb, 12 parts of myrrh, 12 parts of ganoderma lucidum, 10 parts of raw barley , 8 parts of heterophylla, 5 parts of borneol, 10 parts of frankincense, and 20 parts of Hedyotis diffusa; the pharmaceutical composition is prepared into capsules, water pills or decoctions according to conventional preparation techniques.

Embodiment 2

[0009] Example 2, a pharmaceutical composition for the prevention and treatment of colon cancer, the materials are composed by weight: 15 parts of Angelica sinensis, 11 parts of Panax notoginseng, 9 parts of rhubarb, 10 parts of myrrh, 10 parts of Ganoderma lucidum, 9 parts of raw barley , 6 parts of heterophylla, 3 parts of borneol, 9 parts of frankincense, and 15 parts of Hedyotis diffusa; the pharmaceutical composition is prepared into capsules, water pills or decoctions according to conventional preparation techniques.

Embodiment 3

[0010] Example 3, a pharmaceutical composition for the prevention and treatment of colon cancer, the materials are composed by weight: 10 parts of angelica, 8 parts of notoginseng, 6 parts of rhubarb, 8 parts of myrrh, 8 parts of ganoderma lucidum, 8 parts of raw barley , 4 parts of heterophylla, 1 part of borneol, 8 parts of frankincense, and 10 parts of Hedyotis diffusa; the pharmaceutical composition is prepared into capsules, water pills or decoctions according to conventional preparation techniques.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of medicine, and in particular to a pharmaceutical composition for preventing and treating colon cancer. The pharmaceutical composition comprises, by weight, 10-20 parts of Chinese angelica, 8-14 parts of pseudo-ginseng, rhubarb 6-12 parts of, 8-12 parts of myrrh, 8-12 parts of Ganoderma lucidum, 8-10 parts of coix seed, 4-8 parts of Radix Pseudostellariae, 1-5 parts of borneol, 8-10 parts of frankincense and 10-20 parts of Hedyotis diffusa. The aim of the invention is to provide a pharmaceutical composition for preventing and treating colon cancer, and the composition has significant therapeutic effect and fast effectiveness.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a pharmaceutical composition for preventing and treating colon cancer. Background technique [0002] Colon cancer is a common malignant tumor in the gastrointestinal tract. The highest incidence rate is in the 40-50 age group. The etiology is not yet clear, but some diseases, such as familial polyposis, have been recognized as precancerous lesions; colonic adenoma, ulcerative colitis, and colonic schistosomiasis are closely related to the occurrence of colon cancer. Currently, the existing traditional Chinese medicines for the treatment of colon cancer are not effective enough, and the effect is relatively slow, so that patients with colon cancer cannot inhibit tumor growth, or the tumor recurs, metastasizes, and spreads after surgery. Contents of the invention [0003] The object of the present invention is to provide a medicinal composition for preventing and treating colo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8994A61P35/00A61K31/045
Inventor 吴旭
Owner 吴旭
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com